Cargando…
Osthole resensitizes CD133(+) hepatocellular carcinoma cells to cisplatin treatment via PTEN/AKT pathway
The population of CD133 positive cancer cells has been reported to be responsible for drug resistance of hepatocellular carcinoma (HCC). However, the potential molecular mechanism by which CD133(+) HCC cells develop drug resistance is still unclear. In this study, we found that CD133(+) HepG2 and Hu...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425450/ https://www.ncbi.nlm.nih.gov/pubmed/32673286 http://dx.doi.org/10.18632/aging.103484 |